Prevencio Enters National GPO Agreement with MediGroup to Expand Access to AI-Powered Cardiovascular Blood Tests
KIRKLAND, WA, UNITED STATES, September 18, 2025 /EINPresswire.com/ — Prevencio, Inc., a leader in AI-powered cardiovascular diagnostics, today announced a national agreement with MediGroup Physician Services, one of the largest non-acute Group Purchasing Organizations (GPOs) in the United States. The collaboration significantly expands Prevencio’s reach into outpatient clinics, ambulatory centers, and physician practices across MediGroup’s extensive network.
Under the agreement, Prevencio’s innovative HART® blood tests—HART CADhs and HART CVE will be made available to MediGroup’s more than 24,000 healthcare provider members, enabling earlier and more accurate detection and risk assessment of cardiovascular disease. Both tests are backed by extensive multinational clinical validation and more than 20 peer-reviewed publications.
